openPR Logo
Press release

Respiratory Syncytial Virus (RSV) Market Size, Share, Industry, Forecast and outlook (2024-2031)

02-23-2024 11:54 AM CET | Health & Medicine

Press release from: DataM Intelligence 4Market Research

DataM Intelligence

DataM Intelligence

Respiratory Syncytial Virus (RSV) Market

Global Respiratory Syncytial Virus (RSV) Market Set to Double in Size, Reaching USD 2.4 Billion by 2030

The global Respiratory Syncytial Virus (RSV) market, which achieved a notable USD 1.2 billion valuation in 2022, is poised for substantial growth, projected to reach USD 2.4 billion by 2030. A comprehensive market analysis indicates a robust Compound Annual Growth Rate (CAGR) of 10.2% during the forecast period spanning 2024 to 2031. The surge is primarily attributed to the expanding elderly population globally.

Key growth drivers for the Respiratory Syncytial Virus (RSV) therapeutics market include an escalating incidence of RSV infections in infants and young children, enhanced treatment options, and a substantial presence of hospitals and specialty clinics. According to the World Health Organization (WHO), by 2030, one in six individuals globally will be 60 or older, creating a favorable landscape for the market's expansion.

Market Scope and Metrics:

CAGR: 10.2%
Forecast Period: 2024-2031
Size Available for Years: 2021-2030
Segments Covered: Drug Type, Dosage Form, Treatment Type, Distribution Channel, and Region
Regions Covered: North America, Europe, Asia-Pacific, South America, and Middle East & Africa
Fastest Growing Region: Asia-Pacific
Largest Region: North America
Report Insights Covered:
Competitive Landscape Analysis, Company Profile Analysis, Market Size, Share, Growth, Demand, Recent Developments, Mergers and Acquisitions, New Type Launches, Growth Strategies, Revenue Analysis, Porter's Analysis, Pricing Analysis, Regulatory Analysis, Supply-Chain Analysis, and Orthopedic Surgery key Insights.

To know more Insights Download Sample: https://www.datamintelligence.com/download-sample/respiratory-syncytial-virus-market

Market Dynamics:

Increasing Prevalence of RSV is a Key Factor Helping Market Expansion

Respiratory Syncytial Virus (RSV) is a common respiratory virus affecting young children and causing mild to severe respiratory diseases. RSV infections, prevalent in autumn, winter, and early spring, are a leading cause of lower respiratory tract infections in newborns and young children. The rise in RSV incidents, especially among infants and the elderly, is a significant factor propelling market growth.

Rise in Clinical Trials by Key Players Expected to Drive Market Growth

Key players' increased focus on clinical trials is expected to fuel market expansion. Notably, the Nirsevimab medication, developed by Sanofi and AstraZeneca, demonstrated an 83% reduction in RSV baby hospitalizations during a real-world clinical trial. Pfizer also reported positive results from its MATISSE Phase 3 clinical trial for the RSV prefusion vaccine candidate.

High Cost of Disease Management to Hamper Market Growth

The considerable cost of managing RSV, with expenses such as palivizumab ranging from $1,660 to $2,500 per dose, is anticipated to hinder market expansion. The substantial financial burden may impede the global RSV market's growth.

Market Segment Analysis:

The Nirsevimab Segment Expected to Hold Dominant Position

The Nirsevimab segment, a monoclonal antibody targeting respiratory syncytial virus, is projected to dominate the market, accounting for approximately 31.20% in 2022. Product approvals by regulatory bodies and an increasing number of clinical trials are expected to drive segment expansion.

Geographical Share:

North America Holds Dominant Position

North America is estimated to hold about 39.4% of the total market share throughout the forecast period. The region's growing burden of RSV infections, coupled with robust research and development activities, increasing investments, and government initiatives, positions North America as a key driver for the global Respiratory Syncytial Virus (RSV) therapeutics market.

Related Reports:

hematuria treatment market: https://www.datamintelligence.com/research-report/hematuria-treatment-market
beri beri treatment market: https://www.datamintelligence.com/research-report/beri-beri-treatment-market
pellagra treatment market: https://www.datamintelligence.com/research-report/pellagra-treatment-market
klinefelter syndrome treatment market: https://www.datamintelligence.com/research-report/klinefelter-syndrome-treatment-marketacute intermittent porphyria market: https://www.datamintelligence.com/research-report/acute-intermittent-porphyria-market
vertigo treatment market: https://www.datamintelligence.com/research-report/vertigo-treatment-market

Contact Us -
Company Name: DataM Intelligence
Email: info@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -
DataM Intelligence 4Market Research is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Respiratory Syncytial Virus (RSV) Market Size, Share, Industry, Forecast and outlook (2024-2031) here

News-ID: 3397039 • Views:

More Releases from DataM Intelligence 4Market Research

Kidney Transplant Market is expected to reach US$ 10.99 Billion by 2033 | Top key players - Transonic, Sanofi S.A., Organ Recovery Systems, Inc.
Kidney Transplant Market is expected to reach US$ 10.99 Billion by 2033 | Top ke …
Market Size and Growth: The Kidney Transplant Market size reached US$ 7.91 Billion in 2024 and is expected to reach US$ 10.99 Billion by 2033, growing at a CAGR of 3.7% during the forecast period 2025-2033. Kidney Transplant Market report, published by DataM Intelligence, provides in-depth insights and analysis on key market trends, growth opportunities, and emerging challenges. Committed to delivering actionable intelligence, DataM Intelligence empowers businesses to make informed decisions and
Global Heart Transplant Market Set to Soar with Rising Demand for Advanced Cardiac Care 2025 | Top key players - Vygo, SynCardia Systems, LLC, CARMAT.
Global Heart Transplant Market Set to Soar with Rising Demand for Advanced Cardi …
Market Overview: The Global Heart Transplant Market is expected to reach at a Significant CAGR during the forecast period 2024-2031. Heart Transplant Market report, published by DataM Intelligence, provides in-depth insights and analysis on key market trends, growth opportunities, and emerging challenges. Committed to delivering actionable intelligence, DataM Intelligence empowers businesses to make informed decisions and stay ahead of the competition. Through a combination of qualitative and quantitative research methods, it offers
AI in Mental Health Market is expected to reach US$12.69 billion by 2033 | Top key players - Woebot Health, Wysa Ltd, BetterHelp.
AI in Mental Health Market is expected to reach US$12.69 billion by 2033 | Top k …
Market Size and Growth: The Global AI in Mental Health Market reached US$1.95 billion in 2024 and is expected to reach US$12.69 billion by 2033, growing at a CAGR of 22.8% during the forecast period 2025-2033, AI in Mental Health Market report, published by DataM Intelligence, provides in-depth insights and analysis on key market trends, growth opportunities, and emerging challenges. Committed to delivering actionable intelligence, DataM Intelligence empowers businesses to make informed
Metabolic Dysfunction-Associated Steatohepatitis (MASH) Treatment Market is expected to reach US$ 7.64 billion by 2031 | Top key players - Madrigal Pharmaceuticals, Simson Pharma Limited, Dr. Reddy's Laboratories Ltd.
Metabolic Dysfunction-Associated Steatohepatitis (MASH) Treatment Market is expe …
Market Size and Growth: The Global Metabolic Dysfunction-Associated Steatohepatitis (MASH) Treatment Market size reached US$ 1.67 billion in 2023 and is expected to reach US$ 7.64 billion by 2031, growing at a CAGR of 21.8% during the forecast period 2024-2031. Metabolic Dysfunction-Associated Steatohepatitis (MASH) Treatment Market report, published by DataM Intelligence, provides in-depth insights and analysis on key market trends, growth opportunities, and emerging challenges. Committed to delivering actionable intelligence, DataM Intelligence

All 5 Releases


More Releases for RSV

The Rise In The Prevalence Of RSV Infection : Transformative Forces Shaping the …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. What Will the Respiratory Syncytial Virus (RSV) Therapeutics Industry Market Size Be by 2025? The market size for therapeutics treating the respiratory syncytial virus (RSV) has seen significant expansion in the past few years. It is expected to surge from $1.6 billion in 2024 to $2 billion in 2025,
RSV Vaccine Market To Reach 731 million by 2040, Due To Increasing Awareness on …
According to our latest market report "RSV Vaccine Market, Till 2040 by Type of Vaccine, Route of Administration, Target Patient Population, Distribution Channel, Key Geographical Regions and Leading Players", the RSV Vaccine market size is projected to reach USD 731 million by 2040 from USD 1,149 million in current year, during the forecast period. To request quote of this report, please visit: https://www.rootsanalysis.com/reports/rsv-vaccine-market/request-quote.html In the dynamic landscape of preventive therapies for respiratory
RSV Diagnostics Market to Signify Strong Growth by 2024-2031
The RSV (Respiratory Syncytial Virus) Diagnostics market is experiencing significant growth due to the increasing prevalence of RSV infections, advancements in diagnostic technologies, and the rising demand for accurate and rapid diagnostic solutions. RSV is a common respiratory virus that causes infections in the lungs and respiratory tract, particularly affecting infants, young children, and the elderly. Market Overview The global RSV Diagnostics market is projected to witness substantial growth over the coming
Global RSV Diagnostic Products Market Size & Trends
According to a new market research report published by Global Market Estimates, the global RSV diagnostic products market is expected to grow at a CAGR of 11.4% from 2023 to 2028. Ongoing advancements in diagnostic technologies, specifically PCR and rapid point-of-care testing, play a crucial role. These advancements offer heightened accuracy, faster results, and increased accessibility, enabling prompt and precise identification of RSV infections. Browse 147 Market Data Tables and 115 Figures
Respiratory Syncytial Virus (RSV) Therapeutics Market Size to Reach USD 9080.84 …
Respiratory Syncytial Virus (RSV) Therapeutics Market Scope & Overview Respiratory Syncytial Virus (RSV) Therapeutics Market size was USD 1040.65 Million in 2022 and is expected to Reach USD 9080.84 Million by 2030 and grow at a CAGR of 31.1% over the forecast period of 2023-2030. The Respiratory Syncytial Virus (RSV) Therapeutics market is a vibrant, fiercely competitive sector that is essential to digital marketing. The demand for effective has increased as companies
Respiratory Syncytial Virus (RSV) Therapeutics Market - Conquering RSV: Advancin …
Newark, New Castle, USA: The "Respiratory Syncytial Virus (RSV) Therapeutics Market" provides a value chain analysis of revenue for the anticipated period from 2023 to 2031. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors. Respiratory Syncytial Virus (RSV) Therapeutics Market: https://www.growthplusreports.com/report/respiratory-syncytial-virus-rsv-therapeutics-market/8519 This latest report